Attikon University General Hospital
Athens, Greece
8 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 1
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
Lymphoma, B-Cell
Celgene174 enrolled40 locationsNCT04884035
Recruiting
Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There a Difference
Type1diabetes
Attikon Hospital240 enrolled1 locationNCT06646107
Recruiting
Phase 3
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Crohn's Disease (CD)
Takeda120 enrolled96 locationsNCT04779320
Recruiting
Phase 2
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
Non-small Cell Lung CancerMetastatic MelanomaSquamous Cell Carcinoma of the Head and Neck
Iovance Biotherapeutics, Inc.245 enrolled45 locationsNCT03645928
Recruiting
Not Applicable
A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases
CancerBrain
Attikon Hospital15 enrolled2 locationsNCT05564949
Recruiting
The Association Between Glycemic Metrics and Cardiovascular Markers in Patients With Type 1 Diabetes.
Type 1 Diabetes
Attikon Hospital90 enrolled1 locationNCT06978387
Recruiting
Phase 3
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Crohn's DiseaseUlcerative Colitis
Takeda240 enrolled68 locationsNCT05442567
Recruiting
The Effect of Semaglutide on Cardiovascular Markers and Liver Function
Diabetes Type 2
Attikon Hospital50 enrolled1 locationNCT06301191